Showing results (81-90 of 129) with videos related to
Sort By:
Pageof 13
Breast Cancer Research and Treatment|January 29, 2013
Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective studyAdam J Olszewski, Yazan Migdady, Susan K Boolbol, et al.Rhode Island Medical Journal (2013)|February 27, 2023
Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare OccurrenceThomas A Ollila, Thomas P Kishkovich, Adam J Olszewski, et al.The Oncologist|May 31, 2022
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I StudyThomas Ollila, James Butera, Pamela Egan, et al.Rhode Island Medical Journal (2013)|October 2, 2020
Enforcing the "4T": An In-Line Calculator for HIT Antibody Ordering in the Electronic Medical RecordAdam S Zayac, Ross W Hilliard, Adam J Olszewski, et al.Journal of Geriatric Oncology|December 20, 2021
Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myelomaSmith Giri, Sumit Dahal, Susan Bal, et al.Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.Journal of Oncology Practice|February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.Journal of Geriatric Oncology|April 27, 2024
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based studyCourtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.Cancers|March 28, 2025
Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based StudyCourtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.Cancer Biology & Therapy|July 11, 2022
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphomaAndrew Hsu, Kelsey E Huntington, Andre De Souza, et al.Pageof 13